Substrate variations that affect the nucleic acid clamp activity of reverse transcriptases

Size: px
Start display at page:

Download "Substrate variations that affect the nucleic acid clamp activity of reverse transcriptases"

Transcription

1 Substrate variations that affect the nucleic acid clamp activity of reverse transcriptases Iris Oz-Gleenberg, Eytan Herzig, Nickolay Voronin and Amnon Hizi* Department of Cell and Developmental Biology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel Keywords nucleic acids clamp activity; reverse transcriptases; reverse transcription; strand transfer; substrate variations Correspondence A. Hizi, Department of Cell and Developmental Biology, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel Fax: Tel: *A. Hizi is an incumbent of the Gregorio and Dora Shapira Chair for the Research of Malignancies (Received 29 January 2012, revised 29 February 2012, accepted 14 March 2012) doi: /j x We have recently shown that reverse transcriptases (RTs) perform template switches when there is a very short (two-nucleotide) complementarity between the 3 ends of the primer (donor) strand and the DNA or RNA template acceptor strands [Oz-Gleenberg et al. (2011) Nucleic Acids Res 39, ]. These dinucleotide pairs are stabilized by RTs that are capable of clamping together the otherwise unstable duplexes. This RT-driven stabilization of the micro-homology sequence promotes efficient DNA synthesis. In the present study, we have examined several factors associated with the sequence and structure of the DNA substrate that are critical for the clamp activity of RTs from human immunodeficiency virus type 1 (HIV-1), murine leukemia virus (MLV), bovine immunodeficiency virus (BIV) and the long terminal repeat retrotransposon Tf1. The parameters studied were the minimal complementarity length between the primer and functional template termini that sustains stable clamps, the effects of gaps between the two template strands on the clamp activity of the tested RTs, the effects of template end phosphorylations on the RT-associated clamp activities, and clamp activity with a long hairpin double-stranded primer comprising both the primer and the complementary non-functional template strands. The results show that the substrate conditions for clamp activity of HIV-1 and MLV RTs are more stringent, while Tf1 and BIV RTs show clamp activity under less rigorous substrate conditions. These differences shed light on the dissimilarities in catalytic activities of RTs, and suggest that clamp activity may be a potential new target for anti-retroviral drugs. Introduction Reverse transcription is a vital step in the life cycle of retroviruses and related long terminal repeat retrotransposons. This process is performed by retroviral reverse transcriptases (RTs), which convert (+)-sense single-stranded viral RNA into integration-competent double-stranded viral DNA [1 3]. To perform this multi-faceted step, RTs possess DNA polymerase activity, which is both DNA- and RNA-dependent, in addition to ribonuclease H activity that, concomitantly with DNA synthesis, cleaves the genomic RNA template within the generated RNA DNA duplex [4]. DNA synthesis activity produces both ()) and (+) DNA strands, while ribonuclease H removes the RNA primers and the viral genomic RNA template [1,3 5]. Two strand transfers are known to take place during reverse transcription, whereby the 3 end of the growing DNA strand switches to a second template [1 3,5]. In the first transfer, designated ())-strand transfer, the DNA copied from the 5 end of the viral genomic RNA is translocated onto the 3 end of this RNA. Abbreviations BIV, bovine immunodeficiency virus; HIV-1, human immunodeficiency virus type 1; MLV, murine leukemia virus; NTA, non-templated addition; RT, reverse transcriptase; T, template primer FEBS Journal 279 (2012) ª 2012 The Authors Journal compilation ª 2012 FEBS

2 I. Oz-Gleenberg et al. Nucleic acid clamp activity of various RTs In the second switch, the (+)-strand transfer, the 3 end of the (+) DNA strand with the primer binding site sequence switches to a complementary sequence in the ()) DNA strand. These transfers depend on stable sequence complementarities between the ends of the growing (donor) DNA and the acceptor template RNA or DNA strands. These complementary sequences are relatively long. Thus, the primer binding site sequence is usually 18 nucleotides long in most retroviruses, and the sequence promoting ())-strand transfer may even reach 100 nucleotides in length [1,6]. We have recently presented in vitro evidence that RTs perform template switches even with very short complementarities (two nucleotides) between the 3 ends of the primer donor strand and the DNA or RNA template acceptor strands [7]. These dinucleotide duplexes are stabilized by RTs, which clamp together these otherwise unstable duplexes. Consequently, RT-driven stabilization of this sequence micro-homology efficiently promotes DNA synthesis. This apparently newly discovered clamp function is performed by all RTs, but not by cellular DNA polymerases. Thus, this activity potentially affects the efficiency of reverse transcription, allowing the RT-associated DNA synthesis to bridge over nicks in the copied DNA or RNA templates while synthesizing DNA. The combined clamp activity and the capacity of some RTs to perform template-independent blunt-end DNA synthesis also support strand switches during DNA synthesis onto compatible acceptor strands [7,8]. In the present study, we examined the influence of several factors, such as nucleotide sequences, DNA folding and 5 and 3 end phosphorylations, on the clamp activities of a variety of RTs. The studied RTs included those from human immunodeficiency virus type 1 (HIV-1) and murine leukemia virus (MLV), which serve as prototype retroviruses of the lentivirus and gammaretrovirus groups, respectively [1,7]. In addition, we analyzed the RTs from lentivirus, bovine immunodeficiency virus (BIV) [9] and the long terminal repeat retrotransposon Tf1 [10]. Results and Discussion In our previous study, we characterized the clamp activity associated with RTs [7]. Such activity was observed with HIV-1 RT when the primer s 3 end overhang, which is annealed to the 3 end of the functional template (designated ), was at least two nucleotides long. Efficient clamp activity was also shown for the RTs of HIV-2, MLV, Tf1, BIV and avian myeloblastosis virus [7]. Another property of the clamp activity associated with HIV-1 RT was that it is substantial only when the functional template strand (designated ) adjoins a second DNA (or RNA) strand () that is annealed to most of the primer and is located upstream of [7]. We examined here whether these substrate restrictions also apply to the other RTs tested (from BIV, MLV and Tf1). We also determined whether phosphorylating the 3 end of the functional template () and or the 5 end of the adjacent strand () interferes with the correct alignment of the two template strands across the 3 end tail of the primer. Finally, we tested whether a long hairpin substrate, which includes both the primer and its complementary template () sequences, serves as an efficient clamp substrate after adding the strand. All assays used in the present study and previously [7,8] measure the combined two-step clamp DNA polymerase activity, where the initial clamp is followed by DNA synthesis. We have used similar DNA polymerase activities for all tested RTs (data not shown). Thus, the variations in the apparent combined clamp polymerase activities of the tested RTs result solely from differences in clamp activity per se, as the only rate-limiting step in the RT-driven reaction. In the experiments described, we have used the clampdependent DNA synthesis assay, as described previously in detail [7,8]. Minimal length of complementarity between the termini of the primer and functional template strands that supports a stable clamp Each RT was tested for its clamp activity with two sets of primer template substrates. In the first one (designated set #2 and already tested previously [7]), most of the 5 end-labeled 21 nucleotide primer (designated ) is annealed to the non-functional template (), but its last two 3 end nucleotides (with the GT sequence) form an overhang that is complementary to the last two nucleotides (AC) at the 3 end of the functional template (). The second substrate set (#52) is similar to set #2, except that the primer is shorter at its 3 end by a single nucleotide. Accordingly, in this case, only a single-nucleotide duplex (G C) is formed between the 3 end tails of and (see top of Fig. 1). The resulting combined clamp DNA synthesis showed that all tested RTs have efficient activities with two-nucleotide clamps, but to different extents. However, HIV-1 and MLV RTs lost all apparent activity when tested with the single-nucleotide clamp substrate, in contrast to BIV and Tf1 RTs, which were still quite active with this substrate although their activity was substantially lower relative to the two-nucleotide FEBS Journal 279 (2012) ª 2012 The Authors Journal compilation ª 2012 FEBS 1895

3 Nucleic acid clamp activity of various RTs I. Oz-Gleenberg et al. T/ #2 (2nts clamp) T/ #52 (1nt clamp) * 5 ca cg 5 * G 3 5 c cg 5 HIV-1 RT Tf1 RT BIV RT MLV RT rimer 21 rimer Overhang (nts): Clamp (%): ± ± Fig. 1. Urea AGE analysis of combined clamp polymerase activity of the various RTs performed using substrates with oneand two-nucleotide clamp complementarities. Reactions were performed using the indicated T sets and RTs, as described in Experimental procedures. Asterisks indicate the 5 end 32 label. The ends of the primer () and the first template () are indicated by capital letters, and those of the functional template () are indicated by lower-case letters. The percentage clamp formation is the mean of two independent experiments for each RT with each T set. The results were normalized to the value for clamp formation obtained with T set #2 (two-nucleotide overhang). clamp. Thus, Tf1 RT retains approximately 24% of its initial clamp activity (single-nucleotide clamp versus double-nucleotide clamp), while BIV RT retains approximately 36% of its initial activity. Taken together, the data presented in Fig. 1 strongly suggest that ability to form a stable clamp structure between the tails of the primer, the functional template and the RT depends not only on the stability of the nucleic acid duplexes themselves, but also on the specific RT involved in stabilizing these complexes. The RTs from Tf1 and BIV are able to stabilize even a single-nucleotide complementarity between the duplexed, but the HIV-1 and MLV RTs are unable to do so. In the case of Tf1 RT, products significantly longer than the expected 59 nucleotides were also generated for both substrates (Fig. 1, lanes 3 and 4). This results from the high non-templated addition (NTA) (or terminal deoxynucleotide transferase) activity that is typical of Tf1 RT [10,11]. Thus, the 59-nucleotide blunt-ended products of the first combined clamp polymerase activity cycle are extended by a few nucleotides due to this DNA synthesis activity of Tf1 RT. Only these NTA products (which are slightly longer than the initial 59-nucleotide products and have GT or G tails) are further extended by a second round of clamp polymerase activity after annealing to and copying another strand (as molecules are in excess over the duplex). This process generates products that are 99 nucleotides long, i.e. the length of the initial product (59 nucleotides) plus the length of (oligonucleotide #I8, +40 nucleotides; Tables 1 and 2). This phenomenon is apparent in the results obtained with Tf1 RT (Figs 2A and 3). BIV RT also has significant NTA activity, but lower than that of Tf1 RT (data not shown). HIV-1 RT also shows NTA activity, but considerably lower than that for Tf1 and BIV RTs, while MLV RT shows hardly any NTA activity [10 12]. Therefore, some second-cycle products of clamp synthesis were also observed with BIV RT (Figs 2A and 3), but no significant activity was detected with HIV-1 and MLV RTs in any of the experiments (Figs 1 3) FEBS Journal 279 (2012) ª 2012 The Authors Journal compilation ª 2012 FEBS

4 I. Oz-Gleenberg et al. Nucleic acid clamp activity of various RTs Table 1. rimers templates sets used in this study. The designations of the labeled primers are shown for each set, together with the compatible templates. The 5 and 3 ends of the primers and first templates () are indicated by capital letters, and those of the functional template () are indicated by lower-case letters. Nicks or gaps between two adjacent templates (bottom strands) are indicated by arrowheads. Asterisks indicate the [ 32 ] 5 ends of primers. T set 5 end-labeled primer Template Scheme #2 I1 I3, I8 5 * CAGT 3 3 CA GT ca cg 5 #3 I1 I8 5 * CAGT 3 3 ca cg 5 #6 I1 I4, I8 5 * CAGT 3 3 CA G ca cg 5 #9 I1 I5, I8 5 * AGCAGT 3 3 CA TC ca cg 5 #52 I11 I3, I8 5 * CAG 3 3 CA GTca cg 5 #53 I1 I6, I8 5 * TAGCAGT 3 3 CA AT ca gt 5 #54 I1 I85, I8 5 * CA GT 3 3 CA GT-ca cg 5 #55 I1 I3, I86 5 * CA GT 3 3 CA GT -ca ct 5 #56 I1 I85, I86 5 * CA GT 3 3 CA GT--ca cg 5 #64 I94 I8 CCGTGTGGAAAATCTCTAGCAGT-3 C CCCACACCTTTTAGAGATCGT*ca gt-5 #65 I94 Not labeled I8 CCGTGTGGAAAATCTCTAGCAGT-3 C CCCACACCTTTTAGAGATCGT ca gt-5 Effects of gaps between the two adjacent template DNA strands ( and ) on the clamp activity of the tested RTs The nucleic acid clamp model implies that the clamp activity associated with HIV-1 RT depends on tandem alignment of the template strands [7]. Therefore, in order to achieve an efficient clamp, the 3 end of the functional template () must be positioned immediately next to the 5 end of the second template strand () that is annealed to most of the length of the primer (top of Fig. 1) [7]. To further investigate how gaps between the and strands affect efficient clamp activity, we tested the four RTs using a substrate containing no gap (set #2) and similar substrates containing gaps ranging from 1 to 3 nucleotides. These gaps were created by shortening the 5 end of the strand. The data in Fig. 2 show that MLV RT is the most sensitive to gaps introduced between and, as no FEBS Journal 279 (2012) ª 2012 The Authors Journal compilation ª 2012 FEBS 1897

5 Nucleic acid clamp activity of various RTs I. Oz-Gleenberg et al. Table 2. The synthetic oligonucleotides used in this study. Oligonucleotide designations Sequence 5 - to 3 I1 (21-mer) I3 (19-mer) I4 (18-mer) I5 (17-mer) I6 (16-mer) I8 (40-mer) I11 (20-mer) I40 (20-mer) I85 (19-mer) I86 (25-mer) I94 (45-mer) GTGTGGAAAATCTCTAGCAGT TGCTAGAGATTTTCCACAC GCTAGAGATTTTCCACAC CTAGAGATTTTCCACAC TAGAGATTTTCCACAC GCCGGCCCATGGTCTTCCTAGAAAATATCCCCTCAGCCAC GTGTGGAAAATCTCTAGCAG CGTATGCGGCAAGCTTTACC -TGCTAGAGATTTTCCACAC TCCTAGAAAATATCCCCTCAGCCAC- TGCTAGAGATTTTCCACACCCCCCGTGTGGAAAATCTCTAGCAGT A HIV-1 RT Tf1 RT BIV RT MLV RT 59 rimer T/ set: #3 #2 #6 #9 #53 #3 #2 #6 #9 #53 #3 #2 #6 #9 #53 #3 #2 #6 #9 #53 Gap (nts): no no no no B Clamp (%) Gap (nts) 3 HIV-1 RT Tf1 RT BIV RT MLV RT 4 Fig. 2. Effect of gaps between the two template strands on formation of a stable clamp by the tested RTs. Reactions were performed using the indicated T sets and RTs, as described in Experimental procedures. For the description of each T set, see Tables 1 and 2. (A) Urea AGE analysis of the clamp polymerase activity. (B) Results obtained in two independent experiments similar to the one described in (A). The results were normalized to the value for clamp formation obtained with T set #2 (containing no gaps) FEBS Journal 279 (2012) ª 2012 The Authors Journal compilation ª 2012 FEBS

6 I. Oz-Gleenberg et al. Nucleic acid clamp activity of various RTs * T/ #2 ca cg 5 T/ #54 * p-5 ca cg 5 T/ #55 T/ #56 * 3 -p-ca ct 5 * p-5 3 -p-ca ct 5 HIV-1 RT Tf1 RT BIV RT MLV RT Fig. 3. Urea AGE analysis of the clamp polymerase activity of the RTs obtained with phosphorylated templates. Reactions were performed using the indicated T sets and RTs, as described in Experimental procedures. Each T set is described at the top. Lower-case p indicates phosphate groups at the 5 and or 3 ends of the template strands. rimer T/ set: #2 #54 #55 #56 #2 #54 #55 #56 #2 #54 #55 #56 #2 #54 #55 #56 hosphate: no /3 no /3 no /3 no /3 location / / / / rimer 21 clamp activity was detected even with a single-nucleotide gap (Fig. 2A, lane 18). HIV-1 RT is also highly gap-sensitive, with a sharp reduction of approximately 95% in the initial clamp activity after a single-nucleotide gap was introduced (Fig. 2A, lane 3, and Fig. 2B). Longer gaps totally abrogate clamp formation by HIV-1 RT. Similar to the experiment studying the minimal complementarity sequence required for a stable clamp (Fig. 1), the RTs of BIV and Tf1 differ from those of MLV and HIV-1 with regard to gap length. Thus, the clamp activity of BIV RT is reduced by only approximately 44% when a single-nucleotide break was introduced (Fig. 2A, lane 13, and Fig. 2B), but longer gaps totally abolish any clamp formation. The clamp activity of Tf1 RT even tolerates longer gaps. There is only approximately 30% reduction in activity with a single-nucleotide break (Fig. 2A, lane 8). Moreover, even a two-nucleotides gap is accepted by Tf1 RT (with only approximately 72% reduction in activity, Fig. 2A, lane 9, and Fig. 2B); however, a three-nucleotide gap results in almost complete abolishment of the clamp activity (Fig. 2A, lane 10, and Fig. 2B). The apparent disparities between the tested RTs may be explained by the possibility that the 3 end of is extended by the RT towards, thus filling the gaps initially introduced between these two bottom strands. RT variations in gap-filling activity, in which serves as the template, could possibly explain the results observed in Fig. 2. However, in an experiment designed to test this issue, we did not observe differences in the gap-filling activities of the various RTs, suggesting that this is not the reason for the observed differences in the effects of gaps between and on the clamp activity of the RTs (data not shown). Effects of phosphorylating the 5 end of and the 3 end of DNA strands on the clamp activity of the RTs The results presented so far emphasize the importance of the sequence microenvironment near the clamped region in the substrates used. All clamp studies above were performed using a strand with a 5 -OH moiety and a functional template with a free 3 -OH moiety [7,8]. Another factor that may potentially affect the clamp activity may be phosphorylation of either the 5 end of or the 3 end of. To study this issue, we have used custom-synthesized and phosphorylated DNA oligonucleotides that are similar in sequence to those used in set #2, except for their lengths and the presence of a phosphate at either the 5 end of or the 3 end of. FEBS Journal 279 (2012) ª 2012 The Authors Journal compilation ª 2012 FEBS 1899

7 Nucleic acid clamp activity of various RTs I. Oz-Gleenberg et al. The results presented in Fig. 3 and Table 3 show that a phosphate moiety on the 5 end of (T set #54) causes a substantial reduction in the clamp activity of HIV-1 and MLV RTs. Thus, their activity is suppressed by approximately 90% and 52%, respectively, relative to their control activity with non-phosphorylated templates (Fig. 3, lanes 2 and 14, respectively, and Table 3). In contrast, the RTs of Tf1 and BIV were hardly affected (Fig. 3, lanes 6 and 10, respectively, and Table 3). Similarly, the clamp activity obtained with the 3 end-phosphorylated strand (T set #55) is suppressed by approximately 60% and 80%, respectively, for HIV-1 and MLV RTs (Fig. 3, lanes 3 and 15, respectively, and Table 3). However, the Tf1 and BIV RTs were barely affected by 3 end phosphorylation of the 25-nucleotide template (Fig. 3, lanes 7 and 11, respectively). The expected length of the products is 44 nucleotides ( ) 2). When and are both phosphorylated (T set #56), the clamp activity of the Tf1 and BIV RTs was reduced by approximately 65% (Fig. 3, lanes 8 and 12, and Table 3). As expected, the clamp activity of HIV-1 and MLV RTs was fully lost (Fig. 3, lanes 4 and 16, respectively, and Table 3). These results indicate that, in the case of HIV-1 and MLV RTs, substitution of the OH group at either the 5 end of or the 3 end of by the bulkier O 4 group (and or the negative charge contribution of the O 4 group) significantly interferes with stable clamp formation. As the reduction in clamp formation is less pronounced with Tf1 and BIV RTs, these RTs are able to achieve a stable clamp with relatively little interference from a single O 4 moiety or even two O 4 groups. It should be also noted that Tf1 RT pauses quite frequently when tested with 3 endphosphorylated and when both and are phosphorylated (Fig. 3, lanes 7 and 8). In addition, under the conditions used, the Tf1 RT-associated NTA activity yielding products longer than the expected 44 nucleotides is also very pronounced. Table 3. Clamp polymerase activity of RTs obtained with phosphorylated templates in three independent experiments similar to the one described in Fig. 3. The results were normalized to the value for clamp formation obtained with T set #2 (i.e. without template phosphorylation and with regular 5 end labeling of the primer). All values are percentages. RT T #2 T #54 T #55 T #56 HIV ± ± ± 0.3 BIV ± ± ± 2 Tf ± ± 9 35 ± 6 MLV ± ± 4 0 Clamp activity with a long hairpin substrate containing sequences derived from both the primer and the strand The observation of clamp formation by RTs in the presence of the appropriate substrate raises the question of whether nucleic acid structures, which are different from the classical three-oligonucleotide format studied so far [7], also support RT-dependent clamp formation. To assess this, we designed a new substrate: T sets #64 and #65 (Fig. 4 and Tables 1 and 2). Here, the functional primer is extended at its 5 end by a sequence derived from the original strand used in the previous substrate set (oligonucleotide #I3 in T set #2, Tables 1 and 2). Consequently, this 45-nucleotide oligonucleotide (designated #I94) folds back on itself (due to internal sequence pairing), leaving a 3 end GT overhang that is free to form a duplex with the AC tail of the strand (Tables 1 and 2). First, we tested this substrate with 32 5 end-labeled oligonucleotide #I94 and (T set #64). HIV-1 RT showed hardly any combined clamp polymerase activity (Fig. 4A, lane 1), but the other tested RTs were effective to varying extents in using this substrate, with the strongest activity obtained using Tf1 RT (Fig. 4A, lane 2). However, the poor utilization of this unique substrate by HIV-1 RT may not be due to the substrate itself, but instead may result from the fact that the 5 end of the folded oligonucleotide #I94 is phosphorylated by 32 (as this substrate is analogous to substrate set #54 shown above in Fig. 3). As 5 end phosphorylation of substantially reduced the stability of the clamp formed by HIV-1 RT (Fig. 3, lane 2, and Table 3), it is possible that the poor activity observed in Fig. 4A, lane 1, results directly from interference by the 5 end phosphorylation. To test this issue, we repeated this experiment using a non-5 end-labeled oligonucleotide #I94 (Fig. 4B). Synthesis was followed by incorporation of [a 32 ]- labeled dtt. Thus, direct utilization of the hairpin substrate with no interference from 5 end phosphorylation of the 45-nucleotide folded primer was tested. The results show that HIV-1 RT utilizes the long hairpin substrate quite well; hence, the low activity observed with the 5 end-labeled substrate reflects the hindrance imposed by the 5 end O 4 moiety (Fig. 4B, lane 1). The other tested RTs also utilized this substrate quite efficiently (Fig. 4B). Overall, it appears that the order of utilization for this substrate is: Tf1 RT BIV RT > HIV-1 RT > MLV RT. Interestingly, under the assay conditions used, DNA synthesis by Tf1 RT pauses quite frequently, leading to premature terminations. This finding, in addition 1900 FEBS Journal 279 (2012) ª 2012 The Authors Journal compilation ª 2012 FEBS

8 I. Oz-Gleenberg et al. Nucleic acid clamp activity of various RTs A T/ #64 B T/ #65 *5 ca gt 5 5 ca gt 5 HIV-1 RT Tf1 RT BIV RT MLV RT HIV-1 RT Tf1 RT BIV RT MLV RT Fig. 4. Clamp polymerase activity of the tested RTs utilizing a long hairpin substrate. Reactions were performed using the indicated T sets (described at the top) and RTs, as described in Experimental procedures. (A) Urea AGE analysis of the clamp polymerase activity obtained with T set #64 (5 end-labeled with [c 32 ]AT) and the indicated RTs. (B) Urea AGE analysis of the clamp polymerase activity obtained with T set #65 (not labeled at its 5 end) and the indicated RTs. Here, synthesis was followed by adding [a 32 ]labeled dtt (at a final concentration of 5 lm) to the three other non-labeled dnts (each at a final concentration of 50 lm) rimer to the synthesis pattern shown above in Fig. 3 (lanes 7 and 8), suggests that Tf1 RT has marked low processivity of DNA synthesis with some of the substrates used. Conclusions In summary, the tested RTs were shown to differ in their clamp activity when tested with the various substrates. HIV-1 and MLV RTs have more stringent requirements with respect to substrates, while Tf1 and BIV RTs perform clamping under more relaxed conditions. Thus, unlike HIV-1 and MLV RTs, BIV and Tf1 RTs clamp substrates with a single-nucleotide complementarity between the primer and the functional temple strand, and also tolerate short gaps between the two template strands. We have previously suggested that a biological explanation for the clamp activity associated with RTs is the possibility that it allows the RT-associated DNA synthesis to bridge over nicks in the copied DNA or RNA templates while synthesizing DNA [7]. The data presented here show that the RTs of Tf1 and BIV are even able to bridge over gaps in the copied template of one nucleotide, or even two nucleotides, in the case of Tf1 RT. Overall, the four tested RTs may be divided, according to their clamp parameters, into two groups: the first comprising Tf1 and BIV RTs and the second comprising HIV-1 and MLV RTs. Based on sequence alignments [calculated using CLUSTALW pairwise alignment ( clustalw2/)], this overall RT grouping is unexpected because the homology between full-length HIV-1 and BIV RTs (both lentiviruses) is significantly higher (homology score 37) than that between MLV and HIV-1 RTs (homology score 16) or between Tf1 and BIV RTs (homology score 14). Another feature that distinguishes the lentiviral RTs from the RTs of MLV and Tf1 is that the former are heterodimeric in structure, while the latter two are monomeric [3,13]. Based on structure modeling of HIV-1 RT, we previously proposed that a number of residues in HIV-1 RT are associated with clamp activity [7]. These residues are Glu89, Val90, Gln91, Leu92, Lys154, ro157 and Ala158, which are located in the palm sub-domain of the large subunit of the p66 p51 heterodimeric HIV-1 RT [14]. Multiple sequence alignment of the amino acids sequences within the fingers and palm subdomains of the four RTs studied here showed that, out these suggested residues, only ro157 is fully conserved among all tested RTs (Fig. 5). Thus, this alignment does not explain the suggested grouping of RTs according to their clamp activities. Therefore, mutational analyses are being performed to further elucidate these findings. For example, we are testing whether replacing several of the residues in HIV-1 RT (e.g. residues 89 92) by the comparable ones in Tf1 RT converts the clamp activity of HIV-1 RT into activity typical of Tf1 RT. Furthermore, other RTs that belong to additional retroviral groups will be tested to see how general the apparent variations in clamp activity are. The observed differences between the clamp activities of the tested RTs shed light on the disparities between the catalytic functions of these RTs. This FEBS Journal 279 (2012) ª 2012 The Authors Journal compilation ª 2012 FEBS 1901

9 Nucleic acid clamp activity of various RTs I. Oz-Gleenberg et al. RT: Glu 89 Val 90 Gln 91 Leu 92 HIV-1 77 FRELNKRTQDFW-EVQLGIHAGLK-KKKSVTVLDVGDAYFSVLDEDFRKYTAFTIS 134 BIV 76 FRELNKITVKGQ-EFSTGLYGIK-ECEHLTAIDIKDAYFTILHEDFRFTAFSVV 133 MLV 115 LREVNKRVEDIHTVNYNLLSGLSHQWYTVLDLKDAFFCLRLHTSQLFAFEWRD 174 Tf1 117 YKLNKYVKNIYLLIEQLLAKIQ-GSTIFTKLDLKSAYHLIRVRKGDEHKLAFR : :**... : * :*:.*:. : :. ** HIV INNETGIRYQYNVLQGWKGSAIFQSSMTKILEFKKQNDIVIYQYMDDLYVGSDLE 194 BIV 134 VNREGIERFQWNVLQGWVCSAIYQTTTQKIIENIKKSHDVMLYQYMDDLLIGSNRD 193 MLV 175 E-MGISGQLTWTRLQGFKNSTLFDEALHRDLADFRIQHDLILLQYVDDLLLAATSE 233 Tf CRGVFEYLVMYGISTAAHFQYFINTILGEAKESH----VVCYMDDILIHSKSE 224 : :* * :*: :: : :.: : *:**: : : : Lys 154 ro 157 Ala 158 Fig. 5. Multiple sequence alignment of the tested RTs. Alignment was performed using the ClustalW2 multiple sequence alignment tool ( Asterisks indicate positions at which there is a single, fully conserved residue; colons indicate residues with strongly similar properties; full points indicate residues with weakly similar properties. Only the relevant part of the alignment performed with the full protein sequence of each RT is shown. Residues that were suggested in our previous study to be associated with the clamp activity of HIV-1 RT [7] are indicated in bold; their positions (referring to the HIV-1 RT sequence) and amino acid abbreviation are also shown. study may also potentially assist in defining the possible involvement of clamp activity in retroviral reverse transcription in various retroviruses and retroelements. Moreover, such clamp activity may be a new potential target for the development of anti-retroviral drugs. Experimental procedures Reverse transcriptases All purified recombinant RTs carry six-histidine tags, as previously described by us. These RTs were from the BH-10 strain of HIV-1 [15], Moloney MLV [16], the long terminal repeat retrotransposon Tf1 [10] and BIV [9]. The DNA polymerase activities of all tested RTs were normalized as described in detail previously [7]. Oligonucleotides All oligonucleotides were custom-synthesized and HLCpurified by Metabion (Martinsried, Germany) (Tables 1 and 2). Combined clamp polymerase assay reactions All reactions were performed as described previously [7]. In brief, primers were 5 end-labeled using T4 polynucleotide kinase and [c 32 ]AT, and annealed to the appropriate templates (Tables 1 and 2). The molar ratio of templates to primers was 4:1. Reactions were performed using the indicated template primer (T ) sets and 128 nm HIV-1 RT, 122 nm BIV RT, 171 nm MLV RT or 108 nm Tf1 RT, calibrated and assayed as described previously [7]. Reactions were initiated by adding all four dnts, each at a final concentration of 50 lm (unless otherwise indicated) for 30 min at 37 C, and then stopped by adding formamide loading buffer. The reactions were analyzed by urea polyacrylamide gel electrophoresis (urea AGE), followed by autoradiography, as previously described [16,17]. Acknowledgements This research was supported in part by a grant from the Israeli Science Foundation (number ). References 1 Coffin JM, Hughes SH & Varmus HE (1997) Retroviruses. Cold Spring Harbor Laboratory ress, Cold Spring Harbor, NY. 2 Menendez-Arias L & Berkhout B (2008) Special issue on: retroviral reverse transcription. Virus Res 134, Herschhorn A & Hizi A (2010) Retroviral reverse transcriptases. Cell Mol Life Sci 67, Schultz SJ & Champoux JJ (2008) RNase H activity: structure, specificity, and function in reverse transcription. Virus Res 134, Basu V, Song M, Gao L, Rigby ST, Hanson MN & Bambara RA (2008) Strand transfer events during HIV- 1 reverse transcription. Virus Res 134, Le Grice SF (2003) In the beginning : initiation of minus strand DNA synthesis in retroviruses and LTRcontaining retrotransposons. Biochemistry 42, FEBS Journal 279 (2012) ª 2012 The Authors Journal compilation ª 2012 FEBS

10 I. Oz-Gleenberg et al. Nucleic acid clamp activity of various RTs 7 Oz-Gleenberg I, Herschhorn A & Hizi A (2011) Reverse transcriptases can clamp together nucleic acids strands with two complementary bases at their 3 -termini for initiating DNA synthesis. Nucleic Acids Res 39, Oz-Gleenberg I & Hizi A (2011) Strand selections resulting from the combined template-independent DNA synthesis and clamp activities of HIV-1 reverse transcriptase. Biochem Biophys Res Commun 408, Avidan O, Bochner R & Hizi A (2006) The catalytic properties of the recombinant reverse transcriptase of bovine immunodeficiency virus. Virology 351, Kirshenboim N, Hayouka Z, Friedler A & Hizi A (2007) Expression and characterization of a novel reverse transcriptase of the LTR retrotransposon Tf1. Virology, 366, Oz-Gleenberg I, Herzig E & Hizi A (2012) The template-independent DNA synthesis activity associated with the reverse transcriptase of the LTR retrotransposon Tf1. FEBS J 279, Golinelli M & Hughes SH (2002) Nontemplated nucleotide addition by HIV-1 reverse transcriptase. Biochemistry 41, Hizi A & Herschhorn A (2008) Retroviral reverse transcriptases (other than those of HIV-1 and murine leukemia virus): a comparison of their molecular and biochemical properties. Virus Res 134, Jacobo-Molina A, Ding J, Nanni RG, Clark AD Jr, Lu X, Tantillo C, Williams RL, Kamer G, Ferris AL & Clark et al. (1993) Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA. roc Natl Acad Sci USA 90, Sevilya Z, Loya S, Hughes SH & Hizi A (2001) The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is affected by the thumb subdomain of the small protein subunits. J Mol Biol 311, Avidan O, Loya S, Tonjes RR, Sevilya Z & Hizi A (2003) Expression and characterization of a recombinant novel reverse transcriptase of a porcine endogenous retrovirus. Virology 307, Oz-Gleenberg I, Avidan O, Goldgur Y, Herschhorn A & Hizi A (2005) eptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase. J Biol Chem 280, FEBS Journal 279 (2012) ª 2012 The Authors Journal compilation ª 2012 FEBS 1903

Amnon Hizi* Department of Cell and Developmental Biology, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel

Amnon Hizi* Department of Cell and Developmental Biology, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel JOURNAL OF VIROLOGY, Nov. 2008, p. 10906 10910 Vol. 82, No. 21 0022-538X/08/$08.00 0 doi:10.1128/jvi.01370-08 Copyright 2008, American Society for Microbiology. All Rights Reserved. The Reverse Transcriptase

More information

Department of Microbiology, School of Medicine, Box , University of Washington, Seattle, WA 98195, USA

Department of Microbiology, School of Medicine, Box , University of Washington, Seattle, WA 98195, USA Virology 366 (2007) 361 376 www.elsevier.com/locate/yviro Substitution of alanine for tyrosine-64 in the fingers subdomain of M-MuLV reverse transcriptase impairs strand displacement synthesis and blocks

More information

RNase H Cleavage of the 5 End of the Human Immunodeficiency Virus Type 1 Genome

RNase H Cleavage of the 5 End of the Human Immunodeficiency Virus Type 1 Genome JOURNAL OF VIROLOGY, Dec. 2001, p. 11874 11880 Vol. 75, No. 23 0022-538X/01/$04.00 0 DOI: 10.1128/JVI.75.23.11874 11880.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved. RNase

More information

JANUARY 27, 2006 VOLUME 281 NUMBER 4 JOURNAL OF BIOLOGICAL CHEMISTRY 1943

JANUARY 27, 2006 VOLUME 281 NUMBER 4 JOURNAL OF BIOLOGICAL CHEMISTRY 1943 THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 281, NO. 4, pp. 1943 1955, January 27, 2006 2006 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in the U.S.A. Sequence, Distance,

More information

The processivity and fidelity of DNA synthesis exhibited by the reverse transcriptase of bovine leukemia virus

The processivity and fidelity of DNA synthesis exhibited by the reverse transcriptase of bovine leukemia virus Eur. J. Biochem. 269, 859 867 (2002) Ó FEBS 2002 The processivity and fidelity of DNA synthesis exhibited by the reverse transcriptase of bovine leukemia virus Orna Avidan, Michal Entin Meer, Iris Oz and

More information

Human Immunodeficiency Virus Type 2 Reverse Transcriptase Activity in Model Systems That Mimic Steps in Reverse Transcription

Human Immunodeficiency Virus Type 2 Reverse Transcriptase Activity in Model Systems That Mimic Steps in Reverse Transcription JOURNAL OF VIROLOGY, July 2003, p. 7623 7634 Vol. 77, No. 13 0022-538X/03/$08.00 0 DOI: 10.1128/JVI.77.13.7623 7634.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved. Human Immunodeficiency

More information

Self-Priming of Retroviral Minus-Strand Strong-Stop DNAs

Self-Priming of Retroviral Minus-Strand Strong-Stop DNAs Virology 285, 278 290 (2001) doi:10.1006/viro.2001.0970, available online at http://www.idealibrary.com on Self-Priming of Retroviral Minus-Strand Strong-Stop DNAs Marie-Pierre Golinelli and Stephen H.

More information

JOURNAL OF VIROLOGY, Oct. 2000, p Vol. 74, No. 20. Copyright 2000, American Society for Microbiology. All Rights Reserved.

JOURNAL OF VIROLOGY, Oct. 2000, p Vol. 74, No. 20. Copyright 2000, American Society for Microbiology. All Rights Reserved. JOURNAL OF VIROLOGY, Oct. 2000, p. 9668 9679 Vol. 74, No. 20 0022-538X/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Comparison of Second-Strand Transfer Requirements

More information

Introduction retroposon

Introduction retroposon 17.1 - Introduction A retrovirus is an RNA virus able to convert its sequence into DNA by reverse transcription A retroposon (retrotransposon) is a transposon that mobilizes via an RNA form; the DNA element

More information

reads observed in trnas from the analysis of RNAs carrying a 5 -OH ends isolated from cells induced to express

reads observed in trnas from the analysis of RNAs carrying a 5 -OH ends isolated from cells induced to express Supplementary Figure 1. VapC-mt4 cleaves trna Ala2 in E. coli. Histograms representing the fold change in reads observed in trnas from the analysis of RNAs carrying a 5 -OH ends isolated from cells induced

More information

L I F E S C I E N C E S

L I F E S C I E N C E S 1a L I F E S C I E N C E S 5 -UUA AUA UUC GAA AGC UGC AUC GAA AAC UGU GAA UCA-3 5 -TTA ATA TTC GAA AGC TGC ATC GAA AAC TGT GAA TCA-3 3 -AAT TAT AAG CTT TCG ACG TAG CTT TTG ACA CTT AGT-5 OCTOBER 31, 2006

More information

Reverse transcription and integration

Reverse transcription and integration Reverse transcription and integration Lecture 9 Biology 3310/4310 Virology Spring 2018 One can t believe impossible things, said Alice. I dare say you haven t had much practice, said the Queen. Why, sometimes

More information

7.014 Problem Set 7 Solutions

7.014 Problem Set 7 Solutions MIT Department of Biology 7.014 Introductory Biology, Spring 2005 7.014 Problem Set 7 Solutions Question 1 Part A Antigen binding site Antigen binding site Variable region Light chain Light chain Variable

More information

This exam consists of two parts. Part I is multiple choice. Each of these 25 questions is worth 2 points.

This exam consists of two parts. Part I is multiple choice. Each of these 25 questions is worth 2 points. MBB 407/511 Molecular Biology and Biochemistry First Examination - October 1, 2002 Name Social Security Number This exam consists of two parts. Part I is multiple choice. Each of these 25 questions is

More information

Human Genome: Mapping, Sequencing Techniques, Diseases

Human Genome: Mapping, Sequencing Techniques, Diseases Human Genome: Mapping, Sequencing Techniques, Diseases Lecture 4 BINF 7580 Fall 2005 1 Let us review what we talked about at the previous lecture. Please,... 2 The central dogma states that the transfer

More information

Template Dimerization Promotes an Acceptor Invasion-Induced Transfer Mechanism during Human Immunodeficiency Virus Type 1 Minus-Strand Synthesis

Template Dimerization Promotes an Acceptor Invasion-Induced Transfer Mechanism during Human Immunodeficiency Virus Type 1 Minus-Strand Synthesis JOURNAL OF VIROLOGY, Apr. 2003, p. 4710 4721 Vol. 77, No. 8 0022-538X/03/$08.00 0 DOI: 10.1128/JVI.77.8.4710 4721.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved. Template Dimerization

More information

OCCUPATIONAL HEALTH CONSIDERATIONS FOR WORK WITH VIRAL VECTORS

OCCUPATIONAL HEALTH CONSIDERATIONS FOR WORK WITH VIRAL VECTORS OCCUPATIONAL HEALTH CONSIDERATIONS FOR WORK WITH VIRAL VECTORS GARY R. FUJIMOTO, M.D. PALO ALTO MEDICAL FOUNDATION ADJUNCT ASSOCIATE CLINICAL PROFESSOR OF MEDICINE DIVISION OF INFECTIOUS DISEASES AND GEOGRAPHIC

More information

What causes cancer? Physical factors (radiation, ionization) Chemical factors (carcinogens) Biological factors (virus, bacteria, parasite)

What causes cancer? Physical factors (radiation, ionization) Chemical factors (carcinogens) Biological factors (virus, bacteria, parasite) Oncogenes What causes cancer? Chemical factors (carcinogens) Physical factors (radiation, ionization) Biological factors (virus, bacteria, parasite) DNA Mutation or damage Oncogenes Tumor suppressor genes

More information

Molecular Mechanisms by Which Human Immunodeficiency Virus Type 1 Integrase Stimulates the Early Steps of Reverse Transcription

Molecular Mechanisms by Which Human Immunodeficiency Virus Type 1 Integrase Stimulates the Early Steps of Reverse Transcription JOURNAL OF VIROLOGY, Sept. 2007, p. 10037 10046 Vol. 81, No. 18 0022-538X/07/$08.00 0 doi:10.1128/jvi.00519-07 Copyright 2007, American Society for Microbiology. All Rights Reserved. Molecular Mechanisms

More information

JOHN G. JULIAS, ANDREA L. FERRIS, PAUL L. BOYER, AND STEPHEN H. HUGHES* HIV-Drug Resistance Program, NCI-Frederick, Frederick, Maryland

JOHN G. JULIAS, ANDREA L. FERRIS, PAUL L. BOYER, AND STEPHEN H. HUGHES* HIV-Drug Resistance Program, NCI-Frederick, Frederick, Maryland JOURNAL OF VIROLOGY, July 2001, p. 6537 6546 Vol. 75, No. 14 0022-538X/01/$04.00 0 DOI: 10.1128/JVI.75.14.6537 6546.2001 Replication of Phenotypically Mixed Human Immunodeficiency Virus Type 1 Virions

More information

Lecture 2: Virology. I. Background

Lecture 2: Virology. I. Background Lecture 2: Virology I. Background A. Properties 1. Simple biological systems a. Aggregates of nucleic acids and protein 2. Non-living a. Cannot reproduce or carry out metabolic activities outside of a

More information

VIROLOGY. Engineering Viral Genomes: Retrovirus Vectors

VIROLOGY. Engineering Viral Genomes: Retrovirus Vectors VIROLOGY Engineering Viral Genomes: Retrovirus Vectors Viral vectors Retrovirus replicative cycle Most mammalian retroviruses use trna PRO, trna Lys3, trna Lys1,2 The partially unfolded trna is annealed

More information

Life Sciences 1A Midterm Exam 2. November 13, 2006

Life Sciences 1A Midterm Exam 2. November 13, 2006 Name: TF: Section Time Life Sciences 1A Midterm Exam 2 November 13, 2006 Please write legibly in the space provided below each question. You may not use calculators on this exam. We prefer that you use

More information

Section 6. Junaid Malek, M.D.

Section 6. Junaid Malek, M.D. Section 6 Junaid Malek, M.D. The Golgi and gp160 gp160 transported from ER to the Golgi in coated vesicles These coated vesicles fuse to the cis portion of the Golgi and deposit their cargo in the cisternae

More information

Mechanistic Differences in RNA-dependent DNA Polymerization and Fidelity between Murine Leukemia Virus and HIV-1 Reverse Transcriptases*

Mechanistic Differences in RNA-dependent DNA Polymerization and Fidelity between Murine Leukemia Virus and HIV-1 Reverse Transcriptases* THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 280, No. 13, Issue of April 1, pp. 12190 12200, 2005 2005 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Mechanistic Differences

More information

Segment-specific and common nucleotide sequences in the

Segment-specific and common nucleotide sequences in the Proc. Nati. Acad. Sci. USA Vol. 84, pp. 2703-2707, May 1987 Biochemistry Segment-specific and common nucleotide sequences in the noncoding regions of influenza B virus genome RNAs (viral transcription/viral

More information

MODULE 3: TRANSCRIPTION PART II

MODULE 3: TRANSCRIPTION PART II MODULE 3: TRANSCRIPTION PART II Lesson Plan: Title S. CATHERINE SILVER KEY, CHIYEDZA SMALL Transcription Part II: What happens to the initial (premrna) transcript made by RNA pol II? Objectives Explain

More information

LESSON 4.4 WORKBOOK. How viruses make us sick: Viral Replication

LESSON 4.4 WORKBOOK. How viruses make us sick: Viral Replication DEFINITIONS OF TERMS Eukaryotic: Non-bacterial cell type (bacteria are prokaryotes).. LESSON 4.4 WORKBOOK How viruses make us sick: Viral Replication This lesson extends the principles we learned in Unit

More information

Recombinant Protein Expression Retroviral system

Recombinant Protein Expression Retroviral system Recombinant Protein Expression Retroviral system Viruses Contains genome DNA or RNA Genome encased in a protein coat or capsid. Some viruses have membrane covering protein coat enveloped virus Ø Essential

More information

number Done by Corrected by Doctor Ashraf

number Done by Corrected by Doctor Ashraf number 4 Done by Nedaa Bani Ata Corrected by Rama Nada Doctor Ashraf Genome replication and gene expression Remember the steps of viral replication from the last lecture: Attachment, Adsorption, Penetration,

More information

HIV INFECTION: An Overview

HIV INFECTION: An Overview HIV INFECTION: An Overview UNIVERSITY OF PAPUA NEW GUINEA SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY & MOLECULAR BIOLOGY PBL MBBS II SEMINAR VJ

More information

Sequences in the 5 and 3 R Elements of Human Immunodeficiency Virus Type 1 Critical for Efficient Reverse Transcription

Sequences in the 5 and 3 R Elements of Human Immunodeficiency Virus Type 1 Critical for Efficient Reverse Transcription JOURNAL OF VIROLOGY, Sept. 2000, p. 8324 8334 Vol. 74, No. 18 0022-538X/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Sequences in the 5 and 3 R Elements of Human

More information

Viral Genetics. BIT 220 Chapter 16

Viral Genetics. BIT 220 Chapter 16 Viral Genetics BIT 220 Chapter 16 Details of the Virus Classified According to a. DNA or RNA b. Enveloped or Non-Enveloped c. Single-stranded or double-stranded Viruses contain only a few genes Reverse

More information

Phenomena first observed in petunia

Phenomena first observed in petunia Vectors for RNAi Phenomena first observed in petunia Attempted to overexpress chalone synthase (anthrocyanin pigment gene) in petunia. (trying to darken flower color) Caused the loss of pigment. Bill Douherty

More information

For all of the following, you will have to use this website to determine the answers:

For all of the following, you will have to use this website to determine the answers: For all of the following, you will have to use this website to determine the answers: http://blast.ncbi.nlm.nih.gov/blast.cgi We are going to be using the programs under this heading: Answer the following

More information

Received 29 December 1998/Accepted 9 March 1999

Received 29 December 1998/Accepted 9 March 1999 JOURNAL OF VIROLOGY, June 1999, p. 4794 4805 Vol. 73, No. 6 0022-538X/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Molecular Requirements for Human Immunodeficiency

More information

Characterization of the Polymerase and RNase H Activities of Human Foamy Virus Reverse Transcriptase

Characterization of the Polymerase and RNase H Activities of Human Foamy Virus Reverse Transcriptase JOURNAL OF VIROLOGY, June 2004, p. 6112 6121 Vol. 78, No. 12 0022-538X/04/$08.00 0 DOI: 10.1128/JVI.78.12.6112 6121.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved. Characterization

More information

Hands-on Activity Viral DNA Integration. Educator Materials

Hands-on Activity Viral DNA Integration. Educator Materials OVERVIEW This activity is part of a series of activities and demonstrations focusing on various aspects of the human immunodeficiency virus (HIV) life cycle. HIV is a retrovirus. Retroviruses are distinguished

More information

Julianne Edwards. Retroviruses. Spring 2010

Julianne Edwards. Retroviruses. Spring 2010 Retroviruses Spring 2010 A retrovirus can simply be referred to as an infectious particle which replicates backwards even though there are many different types of retroviruses. More specifically, a retrovirus

More information

AIDS - Knowledge and Dogma. Conditions for the Emergence and Decline of Scientific Theories Congress, July 16/ , Vienna, Austria

AIDS - Knowledge and Dogma. Conditions for the Emergence and Decline of Scientific Theories Congress, July 16/ , Vienna, Austria AIDS - Knowledge and Dogma Conditions for the Emergence and Decline of Scientific Theories Congress, July 16/17 2010, Vienna, Austria Reliability of PCR to detect genetic sequences from HIV Juan Manuel

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION doi:10.1038/nature14008 Supplementary Figure 1. Sequence alignment of A/little yellow-shouldered bat/guatemala/060/2010 (H17N10) polymerase with that of human strain A/Victoria/3/75(H3N2). The secondary

More information

Fayth K. Yoshimura, Ph.D. September 7, of 7 RETROVIRUSES. 2. HTLV-II causes hairy T-cell leukemia

Fayth K. Yoshimura, Ph.D. September 7, of 7 RETROVIRUSES. 2. HTLV-II causes hairy T-cell leukemia 1 of 7 I. Diseases Caused by Retroviruses RETROVIRUSES A. Human retroviruses that cause cancers 1. HTLV-I causes adult T-cell leukemia and tropical spastic paraparesis 2. HTLV-II causes hairy T-cell leukemia

More information

Retroviruses. ---The name retrovirus comes from the enzyme, reverse transcriptase.

Retroviruses. ---The name retrovirus comes from the enzyme, reverse transcriptase. Retroviruses ---The name retrovirus comes from the enzyme, reverse transcriptase. ---Reverse transcriptase (RT) converts the RNA genome present in the virus particle into DNA. ---RT discovered in 1970.

More information

Polyomaviridae. Spring

Polyomaviridae. Spring Polyomaviridae Spring 2002 331 Antibody Prevalence for BK & JC Viruses Spring 2002 332 Polyoma Viruses General characteristics Papovaviridae: PA - papilloma; PO - polyoma; VA - vacuolating agent a. 45nm

More information

Human Immunodeficiency Virus (HIV) is a lentivirus

Human Immunodeficiency Virus (HIV) is a lentivirus The Tryptophan Mutant in the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Active Site Jessica Chery, 2008 Advised by Darwin J. Operario, M.S. and Baek Kim, Ph.D. Department of Microbiology

More information

Molecular Biology (BIOL 4320) Exam #2 May 3, 2004

Molecular Biology (BIOL 4320) Exam #2 May 3, 2004 Molecular Biology (BIOL 4320) Exam #2 May 3, 2004 Name SS# This exam is worth a total of 100 points. The number of points each question is worth is shown in parentheses after the question number. Good

More information

Practice Problems 8. a) What do we define as a beneficial or advantageous mutation to the virus? Why?

Practice Problems 8. a) What do we define as a beneficial or advantageous mutation to the virus? Why? Life Sciences 1a Practice Problems 8 1. You have two strains of HIV one is a wild type strain of HIV and the second has acquired a mutation in the gene encoding the protease. This mutation has a dual effect

More information

WHO Prequalification of In Vitro Diagnostics PUBLIC REPORT. Product: Alere q HIV-1/2 Detect WHO reference number: PQDx

WHO Prequalification of In Vitro Diagnostics PUBLIC REPORT. Product: Alere q HIV-1/2 Detect WHO reference number: PQDx WHO Prequalification of In Vitro Diagnostics PUBLIC REPORT Product: Alere q HIV-1/2 Detect WHO reference number: PQDx 0226-032-00 Alere q HIV-1/2 Detect with product codes 270110050, 270110010 and 270300001,

More information

TRANSLATION: 3 Stages to translation, can you guess what they are?

TRANSLATION: 3 Stages to translation, can you guess what they are? TRANSLATION: Translation: is the process by which a ribosome interprets a genetic message on mrna to place amino acids in a specific sequence in order to synthesize polypeptide. 3 Stages to translation,

More information

In Vitro Strand Transfer from Broken RNAs Results in Mismatch but Not Frameshift Mutations

In Vitro Strand Transfer from Broken RNAs Results in Mismatch but Not Frameshift Mutations Virology 276, 7 15 (2000) doi:10.1006/viro.2000.0533, available online at http://www.idealibrary.com on In Vitro Strand Transfer from Broken RNAs Results in Mismatch but Not Frameshift Mutations Jeffrey

More information

numbe r Done by Corrected by Doctor

numbe r Done by Corrected by Doctor numbe r 5 Done by Mustafa Khader Corrected by Mahdi Sharawi Doctor Ashraf Khasawneh Viral Replication Mechanisms: (Protein Synthesis) 1. Monocistronic Method: All human cells practice the monocistronic

More information

HIV & AIDS: Overview

HIV & AIDS: Overview HIV & AIDS: Overview UNIVERSITY OF PAPUA NEW GUINEA SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY & MOLECULAR BIOLOGY PBL SEMINAR VJ TEMPLE 1 What

More information

DATA SHEET. Provided: 500 µl of 5.6 mm Tris HCl, 4.4 mm Tris base, 0.05% sodium azide 0.1 mm EDTA, 5 mg/liter calf thymus DNA.

DATA SHEET. Provided: 500 µl of 5.6 mm Tris HCl, 4.4 mm Tris base, 0.05% sodium azide 0.1 mm EDTA, 5 mg/liter calf thymus DNA. Viral Load DNA >> Standard PCR standard 0 Copies Catalog Number: 1122 Lot Number: 150298 Release Category: A Provided: 500 µl of 5.6 mm Tris HCl, 4.4 mm Tris base, 0.05% sodium azide 0.1 mm EDTA, 5 mg/liter

More information

ABSTRACT. Human immunodeficiency virus reverse transcriptase (HIV-RT) binds more stably in

ABSTRACT. Human immunodeficiency virus reverse transcriptase (HIV-RT) binds more stably in ABSTRACT Title of Document: A COMPARATIVE ANALYSIS OF THE BINDING AFFINITY OF HIV-1 REVERSE TRANSCRIPTASE TO DNA vs. RNA SUBSTRATES Jeffrey T. Olimpo, Jr., Master of Science, 2010 Directed By: Dr. Jeffrey

More information

Biol115 The Thread of Life"

Biol115 The Thread of Life Biol115 The Thread of Life" Lecture 9" Gene expression and the Central Dogma"... once (sequential) information has passed into protein it cannot get out again. " ~Francis Crick, 1958! Principles of Biology

More information

Supplemental Materials and Methods Plasmids and viruses Quantitative Reverse Transcription PCR Generation of molecular standard for quantitative PCR

Supplemental Materials and Methods Plasmids and viruses Quantitative Reverse Transcription PCR Generation of molecular standard for quantitative PCR Supplemental Materials and Methods Plasmids and viruses To generate pseudotyped viruses, the previously described recombinant plasmids pnl4-3-δnef-gfp or pnl4-3-δ6-drgfp and a vector expressing HIV-1 X4

More information

Received 14 August 1997/Accepted 13 November 1997

Received 14 August 1997/Accepted 13 November 1997 JOURNAL OF VIROLOGY, Mar. 1998, p. 2519 2525 Vol. 72, No. 3 0022-538X/98/$04.00 0 Copyright 1998, American Society for Microbiology Extended Minus-Strand DNA as Template for R-U5-Mediated Second-Strand

More information

Norgen s HIV Proviral DNA PCR Kit was developed and validated to be used with the following PCR instruments: Qiagen Rotor-Gene Q BioRad T1000 Cycler

Norgen s HIV Proviral DNA PCR Kit was developed and validated to be used with the following PCR instruments: Qiagen Rotor-Gene Q BioRad T1000 Cycler 3430 Schmon Parkway Thorold, ON, Canada L2V 4Y6 Phone: 866-667-4362 (905) 227-8848 Fax: (905) 227-1061 Email: techsupport@norgenbiotek.com HIV Proviral DNA PCR Kit Product# 33840 Product Insert Intended

More information

VIRUSES AND CANCER Michael Lea

VIRUSES AND CANCER Michael Lea VIRUSES AND CANCER 2010 Michael Lea VIRAL ONCOLOGY - LECTURE OUTLINE 1. Historical Review 2. Viruses Associated with Cancer 3. RNA Tumor Viruses 4. DNA Tumor Viruses HISTORICAL REVIEW Historical Review

More information

Ch. 18 Regulation of Gene Expression

Ch. 18 Regulation of Gene Expression Ch. 18 Regulation of Gene Expression 1 Human genome has around 23,688 genes (Scientific American 2/2006) Essential Questions: How is transcription regulated? How are genes expressed? 2 Bacteria regulate

More information

VIRUSES. 1. Describe the structure of a virus by completing the following chart.

VIRUSES. 1. Describe the structure of a virus by completing the following chart. AP BIOLOGY MOLECULAR GENETICS ACTIVITY #3 NAME DATE HOUR VIRUSES 1. Describe the structure of a virus by completing the following chart. Viral Part Description of Part 2. Some viruses have an envelope

More information

ARV Mode of Action. Mode of Action. Mode of Action NRTI. Immunopaedia.org.za

ARV Mode of Action. Mode of Action. Mode of Action NRTI. Immunopaedia.org.za ARV Mode of Action Mode of Action Mode of Action - NRTI Mode of Action - NNRTI Mode of Action - Protease Inhibitors Mode of Action - Integrase inhibitor Mode of Action - Entry Inhibitors Mode of Action

More information

AP Biology Summer Assignment Chapter 3 Quiz

AP Biology Summer Assignment Chapter 3 Quiz AP Biology Summer Assignment Chapter 3 Quiz 2016-17 Multiple Choice Identify the choice that best completes the statement or answers the question. 1. All of the following are found in a DNA nucleotide

More information

Chapter 19: Viruses. 1. Viral Structure & Reproduction. 2. Bacteriophages. 3. Animal Viruses. 4. Viroids & Prions

Chapter 19: Viruses. 1. Viral Structure & Reproduction. 2. Bacteriophages. 3. Animal Viruses. 4. Viroids & Prions Chapter 19: Viruses 1. Viral Structure & Reproduction 2. Bacteriophages 3. Animal Viruses 4. Viroids & Prions 1. Viral Structure & Reproduction Chapter Reading pp. 393-396 What exactly is a Virus? Viruses

More information

Phenylketonuria (PKU) Structure of Phenylalanine Hydroxylase. Biol 405 Molecular Medicine

Phenylketonuria (PKU) Structure of Phenylalanine Hydroxylase. Biol 405 Molecular Medicine Phenylketonuria (PKU) Structure of Phenylalanine Hydroxylase Biol 405 Molecular Medicine 1998 Crystal structure of phenylalanine hydroxylase solved. The polypeptide consists of three regions: Regulatory

More information

19 Viruses BIOLOGY. Outline. Structural Features and Characteristics. The Good the Bad and the Ugly. Structural Features and Characteristics

19 Viruses BIOLOGY. Outline. Structural Features and Characteristics. The Good the Bad and the Ugly. Structural Features and Characteristics 9 Viruses CAMPBELL BIOLOGY TENTH EDITION Reece Urry Cain Wasserman Minorsky Jackson Outline I. Viruses A. Structure of viruses B. Common Characteristics of Viruses C. Viral replication D. HIV Lecture Presentation

More information

Viral reproductive cycle

Viral reproductive cycle Lecture 29: Viruses Lecture outline 11/11/05 Types of viruses Bacteriophage Lytic and lysogenic life cycles viruses viruses Influenza Prions Mad cow disease 0.5 µm Figure 18.4 Viral structure of capsid

More information

CDC site UNAIDS Aids Knowledge Base http://www.cdc.gov/hiv/dhap.htm http://hivinsite.ucsf.edu/insite.jsp?page=kb National Institute of Allergy and Infectious Diseases http://www.niaid.nih.gov/default.htm

More information

The RNA Polymerase of Influenza Virus, Bound to the 5 End of Virion RNA, Acts in cis To Polyadenylate mrna

The RNA Polymerase of Influenza Virus, Bound to the 5 End of Virion RNA, Acts in cis To Polyadenylate mrna JOURNAL OF VIROLOGY, Oct. 1998, p. 8214 8219 Vol. 72, No. 10 0022-538X/98/$04.00 0 Copyright 1998, American Society for Microbiology. All Rights Reserved. The RNA Polymerase of Influenza Virus, Bound to

More information

Molecular Dynamics of HIV-1 Reverse Transcriptase

Molecular Dynamics of HIV-1 Reverse Transcriptase Molecular Dynamics of HIV-1 Reverse Transcriptase Abderrahmane Benghanem Rensselaer Polytechnic Institute,Troy, NY Mentor: Dr. Maria Kurnikova Carnegie Mellon, Pittsburgh PA Outline HIV-1 Reverse Transcriptase

More information

Genetic information flows from mrna to protein through the process of translation

Genetic information flows from mrna to protein through the process of translation Genetic information flows from mrn to protein through the process of translation TYPES OF RN (RIBONUCLEIC CID) RN s job - protein synthesis (assembly of amino acids into proteins) Three main types: 1.

More information

COMPARISON OF HBV RIBONUCLEASE H DOMAIN IN NAÏVE AND DRUG RESISTANT PATIENTS

COMPARISON OF HBV RIBONUCLEASE H DOMAIN IN NAÏVE AND DRUG RESISTANT PATIENTS HBV RIBONUCLEASE H DOMAIN IN PATIENTS WITH DRUG RESISTANT COMPARISON OF HBV RIBONUCLEASE H DOMAIN IN NAÏVE AND DRUG RESISTANT PATIENTS Surachai Amornsawadwattana, Pattaratida Sa-Nguanmoo, Preeyaporn Vichaiwattana,

More information

Modeling the HIV-1 Intasome: A Prototype View of the Target of Integrase Inhibitors

Modeling the HIV-1 Intasome: A Prototype View of the Target of Integrase Inhibitors Viruses 2010, 2, 2777-2781; doi:10.3390/v2122777 OPEN ACCESS viruses ISSN 1999-4915 www.mdpi.com/journal/viruses Commentary Modeling the HIV-1 Intasome: A Prototype View of the Target of Integrase Inhibitors

More information

Bi 8 Lecture 17. interference. Ellen Rothenberg 1 March 2016

Bi 8 Lecture 17. interference. Ellen Rothenberg 1 March 2016 Bi 8 Lecture 17 REGulation by RNA interference Ellen Rothenberg 1 March 2016 Protein is not the only regulatory molecule affecting gene expression: RNA itself can be negative regulator RNA does not need

More information

Factors That Promote Recombination. during HIV-1 Reverse Transcription and Properties of M184 Drug. Resistant Reverse Transcriptases

Factors That Promote Recombination. during HIV-1 Reverse Transcription and Properties of M184 Drug. Resistant Reverse Transcriptases Factors That Promote Recombination during HIV-1 Reverse Transcription and Properties of M184 Drug Resistant Reverse Transcriptases by Lu Gao Submitted in Partial Fulfillment of the Requirements for the

More information

Supplementary Information. Supplementary Figure 1

Supplementary Information. Supplementary Figure 1 Supplementary Information Supplementary Figure 1 1 Supplementary Figure 1. Functional assay of the hcas9-2a-mcherry construct (a) Gene correction of a mutant EGFP reporter cell line mediated by hcas9 or

More information

Norgen s HIV proviral DNA PCR Kit was developed and validated to be used with the following PCR instruments: Qiagen Rotor-Gene Q BioRad icycler

Norgen s HIV proviral DNA PCR Kit was developed and validated to be used with the following PCR instruments: Qiagen Rotor-Gene Q BioRad icycler 3430 Schmon Parkway Thorold, ON, Canada L2V 4Y6 Phone: (905) 227-8848 Fax: (905) 227-1061 Email: techsupport@norgenbiotek.com HIV Proviral DNA PCR Kit Product # 33840 Product Insert Background Information

More information

CDC website:

CDC website: Hepatitis B virus CDC website: http://www.cdc.gov/ncidod/diseases/hepatitis/slideset/hep_b/slide_1.htm Relevance Key Features es of Hepatitis t B Virus 250 million people infected worldwide. In areas of

More information

Materials and Methods , The two-hybrid principle.

Materials and Methods , The two-hybrid principle. The enzymatic activity of an unknown protein which cleaves the phosphodiester bond between the tyrosine residue of a viral protein and the 5 terminus of the picornavirus RNA Introduction Every day there

More information

October 26, Lecture Readings. Vesicular Trafficking, Secretory Pathway, HIV Assembly and Exit from Cell

October 26, Lecture Readings. Vesicular Trafficking, Secretory Pathway, HIV Assembly and Exit from Cell October 26, 2006 Vesicular Trafficking, Secretory Pathway, HIV Assembly and Exit from Cell 1. Secretory pathway a. Formation of coated vesicles b. SNAREs and vesicle targeting 2. Membrane fusion a. SNAREs

More information

Chapter 19: Viruses. 1. Viral Structure & Reproduction. What exactly is a Virus? 11/7/ Viral Structure & Reproduction. 2.

Chapter 19: Viruses. 1. Viral Structure & Reproduction. What exactly is a Virus? 11/7/ Viral Structure & Reproduction. 2. Chapter 19: Viruses 1. Viral Structure & Reproduction 2. Bacteriophages 3. Animal Viruses 4. Viroids & Prions 1. Viral Structure & Reproduction Chapter Reading pp. 393-396 What exactly is a Virus? Viruses

More information

Biochemistry 2000 Sample Question Transcription, Translation and Lipids. (1) Give brief definitions or unique descriptions of the following terms:

Biochemistry 2000 Sample Question Transcription, Translation and Lipids. (1) Give brief definitions or unique descriptions of the following terms: (1) Give brief definitions or unique descriptions of the following terms: (a) exon (b) holoenzyme (c) anticodon (d) trans fatty acid (e) poly A tail (f) open complex (g) Fluid Mosaic Model (h) embedded

More information

Human Immunodeficiency Virus

Human Immunodeficiency Virus Human Immunodeficiency Virus Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Viruses and hosts Lentivirus from Latin lentis (slow), for slow progression of disease

More information

Virus and Prokaryotic Gene Regulation - 1

Virus and Prokaryotic Gene Regulation - 1 Virus and Prokaryotic Gene Regulation - 1 We have discussed the molecular structure of DNA and its function in DNA duplication and in transcription and protein synthesis. We now turn to how cells regulate

More information

Nature Methods: doi: /nmeth Supplementary Figure 1

Nature Methods: doi: /nmeth Supplementary Figure 1 Supplementary Figure 1 Subtiligase-catalyzed ligations with ubiquitin thioesters and 10-mer biotinylated peptides. (a) General scheme for ligations between ubiquitin thioesters and 10-mer, biotinylated

More information

NC Pol RNA RNA DNA D C T RNA. retroviruses/ Gag Pol Env. E/psi. E/psi RNA. MA CA NC MA Env CA 2-4

NC Pol RNA RNA DNA D C T RNA.   retroviruses/ Gag Pol Env. E/psi. E/psi RNA. MA CA NC MA Env CA 2-4 55 pp.153 160 2005 RN 1. 100nm RN D T http://www.ncbi.nlm.nih.gov/ retroviruses/ ag Pol Env ag 4 6 M N M Env 565-0871 3-1 TEL 06-6879-8348 FX 06-6879-8347 E-mail sakuragi@biken.osaka-u.ac.jp N Pol PR RT

More information

7.012 Problem Set 6 Solutions

7.012 Problem Set 6 Solutions Name Section 7.012 Problem Set 6 Solutions Question 1 The viral family Orthomyxoviridae contains the influenza A, B and C viruses. These viruses have a (-)ss RNA genome surrounded by a capsid composed

More information

Problem Set 5 KEY

Problem Set 5 KEY 2006 7.012 Problem Set 5 KEY ** Due before 5 PM on THURSDAY, November 9, 2006. ** Turn answers in to the box outside of 68-120. PLEASE WRITE YOUR ANSWERS ON THIS PRINTOUT. 1. You are studying the development

More information

YUMI YAMAGUCHI-KABATA AND TAKASHI GOJOBORI* Center for Information Biology, National Institute of Genetics, Mishima , Japan

YUMI YAMAGUCHI-KABATA AND TAKASHI GOJOBORI* Center for Information Biology, National Institute of Genetics, Mishima , Japan JOURNAL OF VIROLOGY, May 2000, p. 4335 4350 Vol. 74, No. 9 0022-538X/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Reevaluation of Amino Acid Variability of the Human

More information

11/15/2011. Outline. Structural Features and Characteristics. The Good the Bad and the Ugly. Viral Genomes. Structural Features and Characteristics

11/15/2011. Outline. Structural Features and Characteristics. The Good the Bad and the Ugly. Viral Genomes. Structural Features and Characteristics Chapter 19 - Viruses Outline I. Viruses A. Structure of viruses B. Common Characteristics of Viruses C. Viral replication D. HIV II. Prions The Good the Bad and the Ugly Viruses fit into the bad category

More information

Hepadnaviruses: Variations on the Retrovirus Theme

Hepadnaviruses: Variations on the Retrovirus Theme WBV21 6/27/03 11:34 PM Page 377 Hepadnaviruses: Variations on the Retrovirus Theme 21 CHAPTER The virion and the viral genome The viral replication cycle The pathogenesis of hepatitis B virus A plant hepadnavirus

More information

19/06/2013. Viruses are not organisms (do not belong to any kingdom). Viruses are not made of cells, have no cytoplasm, and no membranes.

19/06/2013. Viruses are not organisms (do not belong to any kingdom). Viruses are not made of cells, have no cytoplasm, and no membranes. VIRUSES Many diseases of plants and animals are caused by bacteria or viruses that invade the body. Bacteria and viruses are NOT similar kinds of micro-organisms. Bacteria are classified as living organisms,

More information

Identification of Mutation(s) in. Associated with Neutralization Resistance. Miah Blomquist

Identification of Mutation(s) in. Associated with Neutralization Resistance. Miah Blomquist Identification of Mutation(s) in the HIV 1 gp41 Subunit Associated with Neutralization Resistance Miah Blomquist What is HIV 1? HIV-1 is an epidemic that affects over 34 million people worldwide. HIV-1

More information

PROTEIN SYNTHESIS. It is known today that GENES direct the production of the proteins that determine the phonotypical characteristics of organisms.

PROTEIN SYNTHESIS. It is known today that GENES direct the production of the proteins that determine the phonotypical characteristics of organisms. PROTEIN SYNTHESIS It is known today that GENES direct the production of the proteins that determine the phonotypical characteristics of organisms.» GENES = a sequence of nucleotides in DNA that performs

More information

Biological systems interact, and these systems and their interactions possess complex properties. STOP at enduring understanding 4A

Biological systems interact, and these systems and their interactions possess complex properties. STOP at enduring understanding 4A Biological systems interact, and these systems and their interactions possess complex properties. STOP at enduring understanding 4A Homework Watch the Bozeman video called, Biological Molecules Objective:

More information

CDK9 Autophosphorylation Regulates High-Affinity Binding of the Human Immunodeficiency Virus Type 1 Tat P-TEFb Complex to TAR RNA

CDK9 Autophosphorylation Regulates High-Affinity Binding of the Human Immunodeficiency Virus Type 1 Tat P-TEFb Complex to TAR RNA MOLECULAR AND CELLULAR BIOLOGY, Sept. 2000, p. 6958 6969 Vol. 20, No. 18 0270-7306/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. CDK9 Autophosphorylation Regulates

More information

Islamic University Faculty of Medicine

Islamic University Faculty of Medicine Islamic University Faculty of Medicine 2012 2013 2 RNA is a modular structure built from a combination of secondary and tertiary structural motifs. RNA chains fold into unique 3 D structures, which act

More information

Objective: You will be able to explain how the subcomponents of

Objective: You will be able to explain how the subcomponents of Objective: You will be able to explain how the subcomponents of nucleic acids determine the properties of that polymer. Do Now: Read the first two paragraphs from enduring understanding 4.A Essential knowledge:

More information

Chapter 18. Viral Genetics. AP Biology

Chapter 18. Viral Genetics. AP Biology Chapter 18. Viral Genetics 2003-2004 1 A sense of size Comparing eukaryote bacterium virus 2 What is a virus? Is it alive? DNA or RNA enclosed in a protein coat Viruses are not cells Extremely tiny electron

More information

Received 27 November 2006/Accepted 23 October 2007

Received 27 November 2006/Accepted 23 October 2007 JOURNAL OF VIROLOGY, Jan. 2008, p. 719 727 Vol. 82, No. 2 0022-538X/08/$08.00 0 doi:10.1128/jvi.02611-06 Copyright 2008, American Society for Microbiology. All Rights Reserved. Mutations in the U5 Region

More information